COMPARISON OF ROLLOVER VS WASHOUT DAILY INTERFERON ALFACON-1 AND RIBAVIRIN IN THE RETREATMENT OF NON-RESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN FOR HEPATITIS C VIRUS INFECTION

被引：0
|
作者：
Fahmy, Marianne [1 ]
Gabbert, Charles [1 ]
Richards, Lisa [1 ]
Andrews, Barbara G. [1 ]
Kuo, Alexander [1 ]
机构：
[1] UCSD, San Diego, CA USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1023
引用
收藏
页码：814A / 815A
页数：2
相关论文
共 50 条
  • [1] Retreatment of Chronic Hepatitis C with Interferon Alfacon-1/Ribavirin after Nonresponse to Pegylated Interferon/Ribavirin in Veterans
    Patel, Nehali
    Suman, Amitabh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S100 - S101
  • [2] Retreating Chronic Hepatitis C with Daily Interferon Alfacon-1/Ribavirin After Nonresponse to Pegylated Interferon/Ribavirin: DIRECT Results
    Bacon, Bruce R.
    Shiffman, Mitchell L.
    Mendes, Flavia
    Ghalib, Reem
    Hassanein, Tarek
    Morelli, Giuseppe
    Joshi, Shobha
    Rothstein, Kenneth
    Kwo, Paul
    Gitlin, Norman
    HEPATOLOGY, 2009, 49 (06) : 1838 - 1846
  • [3] EFFICACY OF DAILY DOSE CONSENSUS INTERFERON ALFACON-1 (CIFN) AND RIBAVIRIN IN PREVIOUS NON RESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH ADVANCED FIBROSIS FROM CHRONIC HEPATITIS C
    Mantry, Parvez S.
    Barnes, Maisha
    HEPATOLOGY, 2008, 48 (04) : 893A - 894A
  • [4] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
  • [5] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Goncales, Fernando L., Jr.
    Moma, Camila A.
    Vigani, Aline G.
    Angerami, Adriana F. C. F.
    Goncales, Eduardo S. L.
    Tozzo, Raquel
    Pavan, Maria H. P.
    Goncales, Neiva S. L.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [6] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
  • [7] The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
    Abbasi, Fahimeh
    Bamdad, Taravat
    Ghadimi-Moghadam, Abdolkarim
    Chubin, Hamzeh
    Jamalidoust, Marzieh
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (03)
  • [8] Re-Treating Chronic Hepatitis C with Daily Interferon Alfacon-1/Ribavirin After Nonresponse to Pegylated Interferon/Ribavirin: Really Safe and Effective?
    Lo, Gin-Ho
    HEPATOLOGY, 2009, 50 (03) : 988 - 988
  • [9] Analysis of relapse rates in pegylated interferon and ribavirin non-responders treated with daily consensus interferon and ribavirin
    Hassanein, Tarek
    Ghalib, Reem H.
    Zein, Nizar N.
    Rothstein, Kenneth D.
    Joshi, Shobha N.
    Kwo, Paul Yien
    Hammond, Janet
    HEPATOLOGY, 2007, 46 (04) : 824A - 824A
  • [10] Interferon alfacon-1 and ribavirin versus interferon α-2b and ribavirin in the treatment of chronic hepatitis C
    Sjogren, MH
    Sjogren, R
    Holtzmuller, K
    Winston, B
    Butterfield, B
    Drake, S
    Watts, A
    Howard, R
    Smith, M
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (04) : 727 - 732
12345